CanSino CEO Sees Potential in China's Vaccine Market
CanSino Biologics Chairman and CEO Xuefeng Yu highlighted the company’s resilience last year despite China’s falling birth rate and economic…
CanSino Biologics Chairman and CEO Xuefeng Yu highlighted the company’s resilience last year despite China’s falling birth rate and economic…
The deal would provide ‘certainty’ for Moderna’s vaccine portfolio. www.marketwatch.com #Modernas #stock #rallies #deal #patent #dispute #clears #vaccine #pipeline
US Health Secretary Robert F. Kennedy Jr. has tapped two new members for an influential vaccine committee that’s responsible for…
In early December, two political appointees at the Centers for Disease Control and Prevention began an unusual quest: to find…
Moderna (MRNA) stock closed higher on Wednesday after the FDA reversed its earlier refusal-to-file decision on the company’s mRNA-1010 seasonal…
Pulendran told the BBC: “This vaccine, what we term a universal vaccine, elicits a far broader response that is protective…
The pharmaceutical giant expressed optimism that its new flu shot would be available this year, after approval concerns. Listen to…
The figure paid to Crawford & Company Adjusters is eight times the original estimate for the work. www.bbc.com #Firm #assessing…
The United States Food and Drug Administration (FDA) has refused to review Moderna’s application for approval of a flu vaccine,…
Danish researchers were set to begin a controversial United States-funded vaccine trial on newborns in the West African nation of…